Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Study to Compare the Effects of Drug Darolutamide and Drug Enzalutamide on Physical Function, Including Balance and Daily Activity, in Patients With Castration-resistant Prostate Cancer (CRPC)

ClinicalTrials.gov ID: NCT04157088

Public ClinicalTrials.gov record NCT04157088. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Open-label, Multicenter, Phase 2b Study to Evaluate Physical Function, Including Balance and Daily Activity, in Participants With Castration-resistant Prostate Cancer Treated With Darolutamide or Enzalutamide

Study identification

NCT ID
NCT04157088
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Bayer
Industry
Enrollment
30 participants

Conditions and interventions

Interventions

  • Darolutamide (Nubeqa, BAY1841788) Drug
  • Enzalutamide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 16, 2019
Primary completion
Jul 7, 2022
Completion
Jul 7, 2022
Last update posted
Aug 3, 2023

2019 – 2022

United States locations

U.S. sites
7
U.S. states
6
U.S. cities
7
Facility City State ZIP Site status
Oregon Health and Science University Portland Maine 97239
New Jersey Urology, LLC Voorhees Township New Jersey 08043
Montefiore Medical Center The Bronx New York 10461
Duke University Medical Center Durham North Carolina 27710
MidLantic Urology - Bala Cynwyd Bala-Cynwyd Pennsylvania 19004
Bon Secours St. Francis Hospital Greenville South Carolina 29607
Carolina Urological Research Center Myrtle Beach South Carolina 29579

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04157088, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 3, 2023 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04157088 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →